XENiOS AG Revenue and Competitors
Estimated Revenue & Valuation
- XENiOS AG's estimated annual revenue is currently $39.2M per year.
- XENiOS AG's estimated revenue per employee is $251,000
Employee Data
- XENiOS AG has 156 Employees.
- XENiOS AG grew their employee count by -4% last year.
XENiOS AG's People
Name | Title | Email/Phone |
---|
XENiOS AG Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5M | 40 | -18% | $10M | N/A |
#2 | $24.8M | 99 | 29% | N/A | N/A |
#3 | $84.1M | 0 | N/A | $1.2M | N/A |
#4 | $35.6M | 142 | 30% | N/A | N/A |
#5 | $57.5M | 229 | 6% | N/A | N/A |
#6 | $52.7M | 168 | 25% | $129.6M | N/A |
#7 | $21.1M | 84 | -3% | N/A | N/A |
#8 | $61.2M | 244 | -13% | N/A | N/A |
#9 | $60.6M | 193 | 20% | $115.5M | N/A |
#10 | $56.2M | 179 | -3% | $122.9M | N/A |
What Is XENiOS AG?
Xenios AG - a company of the Fresenius Medical Care Group - is a pioneer in extracorporeal heart and lung support. The Novalung and Medos products offer a wide range of heart and lung support products via a single platform, the Xenios console. Xenios' mission is to improve patient well-being and care. Novalung's ECMO therapy aims at a paradigm shift in lung support: Doctors gain time to treat the patient and at the same time the lungs have time to heal. Xenios AG has been part of Fresenius Medical Care, the world's leading provider of products and services for people with kidney disease since the end of 2016. Xenios complements the group's portfolio in the area of holistic multi-organ support of FME.
keywords:N/AN/A
Total Funding
156
Number of Employees
$39.2M
Revenue (est)
-4%
Employee Growth %
N/A
Valuation
N/A
Accelerator
XENiOS AG News
... Vital Therapies, Xenios AG, Asahi Kasei Medical Co. Ltd., Medtronic, HeartWare International, Fresenius Medical Care AG & Co.
Xenios AG, Abbott Diabetes Care, Inc. (USA), Terumo Heart, Inc. (USA), Baxter International, Inc. (USA), Asahi Kasei Medical Co.
Getinge Group, Medtronic plc, LivaNova PLC, XENIOS AG, Terumo Corporation, MicroPort Scientific Corporation, NIPRO Corporation, OriGen Biomedical, ALung...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $34.1M | 214 | 0% | N/A |
#2 | $34.8M | 218 | 60% | N/A |
#3 | $56.6M | 286 | 28% | N/A |